Orgenesis is a pioneering global biotech company which is unlocking the full potential of personalized therapies and closed processing systems through its Cell & Gene Therapy Biotech Platform, with the ultimate aim of providing life changing treatments at the point of care (POCare) to large numbers of patients at low cost. The Platform consists of: (a) POCare Therapeutics, a pipeline of licensed cell and gene therapies (CGTs), and proprietary scientific knowhow; (b) POCare Technologies, a suite of proprietary and in-licensed technologies which are engineered to create customized processing systems for affordable point of care therapies; and (c) POCare Network, a collaborative, international ecosystem of leading research institutes and hospitals committed to clinical development and supply of CGTs at the point of care. By combining science, technologies and a collaborative network, Orgenesis is able to identify the most promising new therapies and provide a pathway for them to reach patients more quickly, more efficiently and at scale, thereby unlocking the power of cell and gene therapy for all.
Orgenesis Inc. (Corporate Headquarters)
20271 Goldenrod Lane
Germantown, MD 20876
Atvio Biotech Ltd.
8 HaHaruv St. Bar Lev Industrial Park M.P.
CureCell Co. Ltd
South Korea, Gyeonggi-do, Suwon-si, Yeongtong-gu, Gwanggyo-ro, 156 KR Gwanggyo
Business Center #601
Pharmaceutical Preparation Manufacturing (325412)
Pharmaceutical Preparations (2834)